A cross-sectional study to assess the clinical utility of modern visual function assessments in patients with inherited retinal disease

niversity of Oxford0 个研究点目标入组 81 人开始时间: 2022年8月18日最近更新: 2024年1月29日

试验速览

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/37226218/ (added 25/05/2023)

•Patient participants:
•1. Participant is willing & able to give informed consent for participation in the study.
•2. Male or female, aged 16 years or above, there is no upper age limit.
•3. An inherited retinal degeneration diagnosis
•4. A minimum of 6/60 standard VA in each eye.
•5. Able to participate in visual function testing.
•Control participants:
•1. Participant is willing & able to give informed consent for participation in the study.
•2. Male or female, aged 16 years or above, there is no upper age limit.
•3. A minimum standard VA of 6/7.5 in each eye – this will only become apparent once the participant starts the study, if it is clear they do not meet this criterion, they will be excluded from the study and no further testing undertaken.
•4. Able to participate in visual function testing.

•Patient participants:
•1. Pre-existing amblyopia or squint would exclude that eye, but other eye still eligible
•2. History of other eye problems except those relevant to the study, or glasses or contact lenses, if eye problem in just one eye, the other eye is still eligible
•3. Been involved in an interventional research trial where they have received a treatment for their eye condition.
•Control participants:
•1. Pre-existing amblyopia or squint, fellow eye still eligible
•2. History of eye problems, eye treatment or eye surgery other than glasses or contact lenses, if in one eye, fellow eye still eligible.

发起方